SCHEMBL23369222

SCHEMBL23369222

CS(=O)(=O)Nc1ccc2c(c1)/C(=C\c1cnc[nH]1)C(=O)N2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDPK1 O15530 4/20 1.00
▸ NEK2 P51955 1/20 0.63
▸ TLK2 Q86UE8 12/20 0.63
▸ CDK5 Q00535 3/20 0.62
▸ NTRK1 P04629 3/20 0.62
▸ CDK1 P06493 2/20 0.62
▸ RET P07949 2/20 0.62
▸ CDK2 P24941 2/20 0.62
▸ MAPK1 P28482 2/20 0.62
▸ KDR P35968 2/20 0.62
▸ GSK3A P49840 2/20 0.62
▸ GSK3B P49841 2/20 0.62
▸ CDK7 P50613 2/20 0.62
▸ CDK9 P50750 2/20 0.62
▸ MAPT P10636 2/20 0.62
▸ CDK5R1 Q15078 2/20 0.62
▸ SMN1; SMN2 Q16637 2/20 0.62
▸ PLK4 O00444 1/20 0.62
▸ CHEK1 O14757 1/20 0.62
▸ AURKA O14965 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17679290 1.00 PDPK1 (1.00) PDPK1NEK2TLK2CDK5NTRK1
SCHEMBL17679344 0.86 PDPK1 (0.74) PDPK1NEK2TLK2CDK5NTRK1
SCHEMBL17674505 0.86 PDPK1 (0.74) PDPK1NEK2TLK2CDK5NTRK1
SCHEMBL23369116 0.86 PDPK1 (0.74) PDPK1NEK2TLK2CDK5NTRK1
SCHEMBL5727801 0.82 PDPK1 (1.00) PDPK1NEK2TLK2NTRK1CDK1
SCHEMBL5373720 0.82 PDPK1 (1.00) PDPK1NEK2TLK2NTRK1CDK1
SCHEMBL9921923 0.80 TLK2 (0.72) PDPK1NEK2TLK2CDK5NTRK1
SCHEMBL19709650 0.77 TLK2 (0.68) PDPK1NEK2TLK2CDK5NTRK1
Su-9516 SCHEMBL1170687 0.77 TLK2 (1.00) PDPK1NEK2TLK2CDK5NTRK1
SCHEMBL12064437 0.77 TLK2 (0.67) PDPK1NEK2TLK2CDK5NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023001942-A1 14-3-3 PROTEIN MODULATORS AS ANTITUMOR AGENTS RAPPOSELLI SIMONA (IT) 2023-01-26 — — WO disclosed
EP-3204002-B1 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF TUMORS INTERNATIONAL SOC FOR DRUG DEVELOPMENT S R L (IT) 2021-05-19 — — EP disclosed
Send feedback